Back to Search
Start Over
Neurofibromatosis: part 2--clinical management.
- Source :
-
Arquivos de neuro-psiquiatria [Arq Neuropsiquiatr] 2015 Jun; Vol. 73 (6), pp. 531-43. - Publication Year :
- 2015
-
Abstract
- Part 1 of this guideline addressed the differential diagnosis of the neurofibromatoses (NF): neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SCH). NF shares some features such as the genetic origin of the neural tumors and cutaneous manifestations, and affects nearly 80 thousand Brazilians. Increasing scientific knowledge on NF has allowed better clinical management and reduced rate of complications and morbidity, resulting in higher quality of life for NF patients. Most medical doctors are able to perform NF diagnosis, but the wide range of clinical manifestations and the inability to predict the onset or severity of new features, consequences, or complications make NF management a real clinical challenge, requiring the support of different specialists for proper treatment and genetic counseling, especially in NF2 and SCH. The present text suggests guidelines for the clinical management of NF, with emphasis on NF1.
- Subjects :
- Disease Management
Humans
Neurilemmoma complications
Neurilemmoma pathology
Neurofibromatoses complications
Neurofibromatoses pathology
Neurofibromatosis 1 complications
Neurofibromatosis 1 pathology
Neurofibromatosis 2 complications
Neurofibromatosis 2 pathology
Optic Nerve Glioma pathology
Optic Nerve Glioma therapy
Risk Factors
Skin Neoplasms complications
Skin Neoplasms pathology
Neurilemmoma therapy
Neurofibromatoses therapy
Neurofibromatosis 1 therapy
Neurofibromatosis 2 therapy
Skin Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1678-4227
- Volume :
- 73
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Arquivos de neuro-psiquiatria
- Publication Type :
- Academic Journal
- Accession number :
- 26083891
- Full Text :
- https://doi.org/10.1590/0004-282X20150042